Prior postings and presentation: The research findings were presented at the International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 2012, Barcelona, Spain.
Topiramate use in pregnancy and the birth prevalence of oral clefts†
Version of Record online: 1 APR 2014
Copyright © 2014 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 23, Issue 10, pages 1017–1025, October 2014
How to Cite
2014), Topiramate use in pregnancy and the birth prevalence of oral clefts, Pharmacoepidemiol Drug Saf, 23; pages 1017–1025, doi: 10.1002/pds.3612, , , , , , , , , , , , , , , , and (
- Issue online: 14 OCT 2014
- Version of Record online: 1 APR 2014
- Manuscript Accepted: 17 FEB 2014
- Manuscript Revised: 23 JAN 2014
- Manuscript Received: 8 AUG 2013
- Vivus, Inc.
|pds3612-sup-0001-DocS1.docx||Word 2007 document||128K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.